Crescent Biopharma (CBIO) Operating Income Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 55.96% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -31.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.23% |
| Dec 31, 2025 | -104.98% |
| Sep 30, 2025 | -43.46% |
| Jun 30, 2025 | -16.35% |
| Mar 31, 2025 | 1.00% |
| Dec 31, 2024 | 0.45% |
| Sep 30, 2024 | 46.66% |
| Jun 30, 2024 | 10.41% |
| Mar 31, 2024 | 8.01% |
| Dec 31, 2023 | 14.91% |
| Sep 30, 2023 | 10.58% |
| Jun 30, 2023 | 14.13% |
| Mar 31, 2023 | -10.50% |
| Dec 31, 2022 | 11.52% |
| Sep 30, 2022 | 14.66% |
| Jun 30, 2022 | 7.40% |
| Mar 31, 2022 | 1.05% |
| Dec 31, 2021 | -5.22% |
| Sep 30, 2021 | -11.46% |
| Jun 30, 2021 | -5.84% |
| Mar 31, 2021 | -5.53% |
| Dec 31, 2020 | -17.75% |
| Sep 30, 2020 | -18.83% |
| Jun 30, 2020 | -19.61% |
| Mar 31, 2020 | -0.57% |
| Dec 31, 2019 | -22.42% |
| Sep 30, 2019 | -21.38% |
| Jun 30, 2019 | -27.60% |
| Mar 31, 2019 | -25.94% |
| Dec 31, 2018 | -18.95% |
| Sep 30, 2018 | -20.41% |
| Jun 30, 2018 | -46.89% |
| Mar 31, 2018 | -19.54% |
| Dec 31, 2017 | -8.83% |
| Sep 30, 2017 | -6.89% |
| Jun 30, 2017 | -44.58% |
| Mar 31, 2017 | -16.00% |
| Dec 31, 2016 | -29.29% |
| Sep 30, 2016 | -28.69% |
| Jun 30, 2016 | -32.28% |
| Mar 31, 2016 | -164.54% |